The Psychology of Drugs & Risk Friday, March 9, 6-9pm CUNY Grad Center, Fifth Ave & 34th Street, Rm 6304 This event is free and open to the public. For more information contact Rachel Liebert, rliebert@gc.cuny.edu
Following the thalidomide disaster in 1962, we put a series of protections in place -patent products for drugs, prescription-only status and randomized controlled trials (RCTs). These protections are now fueling an epidemic of drug-induced deaths, with treatment related death now the 4 th leading cause of death and in some branches of medicine the leading cause of death. With Alice it seems the Risks of Drugs have stepped through the Looking Glass -despite increasing evidence for instance that antidepressants double the rate of birth defects, and miscarriages and lead to mental handicap, prescriptions for these drugs in pregnancy are soaring. The protections we have put in place to save ourselves from Drug Risks as so often happens have become the source of an even bigger set of problems. This is particularly the case with RCTs and Prescription-only Status for Medicines. There are a well-known set of biases stemming from RCT methodology and company publication strategies for studies that compromise clinical practice, but this lecture moves beyond these to an unrecognized set of biases inherent in RCTs that make them unsuitable for assessing adverse events. These biases conspire to make medicines appear safer and safer at a cost of making doctors riskier and riskier. If unchecked these biases threaten an end to the professional status of medicine. Treating the growing crisis in medicine will require remedies targeting one or more of these factors. In the meantime, anyone who wants to speak up for those being injured by treatments will have to cope with the appearances of being against 'science' and the question for each of us is whether we can manage to cope with the crisis of identity this will cause.
David Healy, MD, author of many books analyzing and challenging the pharmaceutical industry, has another one just coming out, Pharmageddon (University of California Press, 2012 
Seeing Ourselves
Opening reception: Saturday, March 10, 7-10pm Exhibit runs March 6-April 14 MUSECPMI Museum, 580 Eighth Avenue, 7th Floor (at 38 th St.) http://www.musecpmi.org/currentexhibition.html "Seeing Ourselves" is a unique exhibit in which world class art will be combined with cutting edge science to leave viewers inspired by the beauty and capabilities of the human brain. While many scientific advances have inspired artists over the years, art and medicine have a special area of overlap in the desire to represent the human mind and body. As demonstrated in two groundbreaking articles in the March, 2010 issue of Radiology, new MRI technology allows us to see details in the living brain that were previously seen only through the lens of a low-powered microscope. This important step has excited the scientific world, but has not yet been shared with the art world or with the general public. High-resolution MRIs will be displayed side-by-side with the artwork they have inspired, allowing viewers to marvel at both the structural beauty of the brain and the creative potential housed inside of it.
Featuring art by more than 50 artists, including Laura Ferguson, whose works come directly out of her artist residency at NYUSOM and the access she had to the 3D Imaging Lab and 
